department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Alentis Therapeutics AG · pharmadog

PUBLIC COMPANY

Alentis Therapeutics AG

updated 1mo ago

community read0 votes

pipeline

2

marketed

0

phase 3

0

catalysts ytd

1

approvals ytd

0

recalls ytd

0

Pipeline(2)

pipeline depth2 products

1Phase 21Unknown

Cervical Cancer

Upcoming

no upcoming catalysts on record

Recent(90d)

phase 2 completion (1)

view all catalysts →

🐶 Hiring Signal

No open roles indexed yet — view Alentis Therapeutics AG jobs →

News

no news has mentioned this company yet

identifiers

source

globaldata

top tags

mentioned in

0news items

entity-linker matched

phase 2 completion

Alentis Therapeutics AG — lixudebart (Phase II Trial Completion)

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Active trials

phase2A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumorsrecruitingn=180
phase2A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumorsrecruitingn=170
phase2Rescue of Nephrons With ALE.F02 (RENAL-F02)recruitingn=80
phase2Study of ALE.C04 in Patients With Head and Neck Cancerterminatedn=21
phase1A Clinical Trial of ALE.F02 in Patients With Advanced Liver Fibrosis and/or With Mild Cirrhosiscompletedn=41

🐶 often sniffed alongside

top 5

tagImmunology1 co-mentions · 1 sources
tagNephrology1 co-mentions · 1 sources
tagMonoclonal Antibody1 co-mentions · 1 sources
drugImmunology1 co-mentions · 1 sources
druglixudebart1 co-mentions · 1 sources